BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 27398803)

  • 1. Polycystic kidney disease and cancer after renal transplantation.
    Wetmore JB; Calvet JP; Yu AS; Lynch CF; Wang CJ; Kasiske BL; Engels EA
    J Am Soc Nephrol; 2014 Oct; 25(10):2335-41. PubMed ID: 24854270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of
    Srisuwarn P; Sutharattanapong N; Disthabanchong S; Kantachuvesiri S; Kitiyakara C; Phakdeekitcharoen B; Ingsathit A; Sumethkul V
    Transpl Int; 2024; 37():11614. PubMed ID: 38468637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer incidence in kidney transplant recipients: a study protocol.
    Pita-Fernandez S; Valdes-Cañedo F; Pertega-Diaz S; Seoane-Pillado MT; Seijo-Bestilleiro R
    BMC Cancer; 2009 Aug; 9():294. PubMed ID: 19698143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer cluster among small village residents near the fertilizer plant in Korea.
    Lim H; Lee YH; Bae S; Koh DH; Yoon M; Lee BE; Kim JS; Kwon HJ
    PLoS One; 2021; 16(2):e0247661. PubMed ID: 33630917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer risks in recipients of renal transplants: a meta-analysis of cohort studies.
    Wang Y; Lan GB; Peng FH; Xie XB
    Oncotarget; 2018 Mar; 9(20):15375-15385. PubMed ID: 29632651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors for cancer in people with type 1 diabetes, stratified by stages of diabetic kidney disease: a nationwide Finnish cohort study.
    Feodoroff M; Harjutsalo V; Mäkimattila S; Groop PH;
    Lancet Reg Health Eur; 2024 May; 40():100884. PubMed ID: 38533378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer in Costello syndrome: a systematic review and meta-analysis.
    Astiazaran-Symonds E; Ney GM; Higgs C; Oba L; Srivastava R; Livinski AA; Rosenberg PS; Stewart DR
    Br J Cancer; 2023 Jun; 128(11):2089-2096. PubMed ID: 36966234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for stratification of person-time and events - a prerequisite for Poisson regression and SIR estimation.
    Rostgaard K
    Epidemiol Perspect Innov; 2008 Nov; 5():7. PubMed ID: 19014582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of solid organ transplantation on the risk of developing thyroid cancer: a systematic review and meta-analysis.
    Hu L; Wu Y; Ju F; Zhang Y; Wang W
    Gland Surg; 2022 Apr; 11(4):710-719. PubMed ID: 35531105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel non-cystic features of polycystic kidney disease: having new eyes or seeking new landscapes.
    Van Laecke S; Van Biesen W
    Clin Kidney J; 2021 Mar; 14(3):746-755. PubMed ID: 33777359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Risks in Solid Organ Transplant Recipients: Results from a Comprehensive Analysis of 72 Cohort Studies.
    Huo Z; Li C; Xu X; Ge F; Wang R; Wen Y; Peng H; Wu X; Liang H; Peng G; Li R; Huang D; Chen Y; Zhong R; Cheng B; Xiong S; Lin W; He J; Liang W
    Oncoimmunology; 2020 Nov; 9(1):1848068. PubMed ID: 33299661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thanatometabolomics: introducing NMR-based metabolomics to identify metabolic biomarkers of the time of death.
    Mora-Ortiz M; Trichard M; Oregioni A; Claus SP
    Metabolomics; 2019 Mar; 15(3):37. PubMed ID: 30834988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection.
    Schrem H; Kurok M; Kaltenborn A; Vogel A; Walter U; Zachau L; Manns MP; Klempnauer J; Kleine M
    Liver Transpl; 2013 Nov; 19(11):1252-61. PubMed ID: 24106037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kidney transplant and cancer risk: an epidemiological study in Northern and Central Italy].
    Piselli P; Busnach G; Citterio F; Richiardi L; Cimaglia C; Angeletti C; Doringhet PV; Pozzetto U; Perrino ML; Serraino D
    Epidemiol Prev; 2008; 32(4-5):205-11. PubMed ID: 19186502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of renal cancer in liver transplant recipients: A systematic review and meta-analysis.
    Zhu X; Wang JZ; Zhang Y; Xu M; Chen P; Wang CZ
    Int J Surg; 2016 Jan; 25():128-33. PubMed ID: 26703380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of Standardized Incidence Ratios (SIR) of non-lymphoid de novo malignancies after liver transplantation: Structured analysis of global differences.
    Patel JA; Daoud D; Jain A
    Transplant Rev (Orlando); 2022 Jan; 36(1):100670. PubMed ID: 34688986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent Pre-Transplant Recipient Cancer Risk Factors after Kidney Transplantation and the Utility of G-Chart Analysis for Clinical Process Control.
    Schrem H; Schneider V; Kurok M; Goldis A; Dreier M; Kaltenborn A; Gwinner W; Barthold M; Liebeneiner J; Winny M; Klempnauer J; Kleine M
    PLoS One; 2016; 11(7):e0158732. PubMed ID: 27398803
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.